Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pneumonectomy | 34 | 2023 | 1091 | 4.400 |
Why?
|
Tracheal Neoplasms | 16 | 2021 | 124 | 3.580 |
Why?
|
Thoracic Surgical Procedures | 10 | 2019 | 342 | 2.670 |
Why?
|
Esophagectomy | 19 | 2022 | 447 | 2.090 |
Why?
|
Lung Neoplasms | 36 | 2023 | 12985 | 1.790 |
Why?
|
Thoracic Surgery | 11 | 2019 | 715 | 1.690 |
Why?
|
Esophageal Neoplasms | 16 | 2022 | 1575 | 1.320 |
Why?
|
Tracheal Stenosis | 7 | 2021 | 226 | 1.300 |
Why?
|
Societies, Medical | 14 | 2019 | 3739 | 1.160 |
Why?
|
Respiratory Paralysis | 2 | 2016 | 31 | 1.150 |
Why?
|
Thoracic Surgery, Video-Assisted | 8 | 2023 | 279 | 1.080 |
Why?
|
Recurrent Laryngeal Nerve | 2 | 2016 | 139 | 1.050 |
Why?
|
Diaphragm | 2 | 2016 | 347 | 1.020 |
Why?
|
Thymectomy | 2 | 2015 | 192 | 0.950 |
Why?
|
Thoracic Wall | 3 | 2019 | 201 | 0.930 |
Why?
|
Mediastinal Neoplasms | 4 | 2018 | 421 | 0.880 |
Why?
|
Postoperative Complications | 29 | 2022 | 15194 | 0.860 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2020 | 266 | 0.850 |
Why?
|
Laryngeal Neoplasms | 5 | 2010 | 509 | 0.830 |
Why?
|
Tracheal Diseases | 5 | 2007 | 113 | 0.790 |
Why?
|
Databases, Factual | 17 | 2021 | 7690 | 0.760 |
Why?
|
Respiration | 2 | 2016 | 1650 | 0.720 |
Why?
|
Biomedical Research | 4 | 2019 | 3301 | 0.710 |
Why?
|
Tracheostomy | 2 | 2021 | 402 | 0.680 |
Why?
|
Laryngectomy | 4 | 2010 | 244 | 0.660 |
Why?
|
Intubation, Intratracheal | 6 | 2021 | 1349 | 0.660 |
Why?
|
Carcinoma, Adenoid Cystic | 6 | 2019 | 253 | 0.590 |
Why?
|
Trachea | 8 | 2012 | 1074 | 0.590 |
Why?
|
Postoperative Hemorrhage | 1 | 2020 | 410 | 0.560 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 8 | 2022 | 5154 | 0.540 |
Why?
|
Bronchial Neoplasms | 5 | 2006 | 112 | 0.530 |
Why?
|
Tracheoesophageal Fistula | 3 | 2018 | 128 | 0.490 |
Why?
|
Pleural Neoplasms | 4 | 2020 | 606 | 0.480 |
Why?
|
Esophagus | 8 | 2012 | 1017 | 0.460 |
Why?
|
Anemia, Hemolytic | 1 | 2014 | 168 | 0.450 |
Why?
|
Registries | 4 | 2017 | 8039 | 0.450 |
Why?
|
Pneumonia | 2 | 2023 | 2102 | 0.440 |
Why?
|
Neoplasm Staging | 15 | 2022 | 10961 | 0.440 |
Why?
|
Pulmonary Veno-Occlusive Disease | 2 | 2013 | 66 | 0.440 |
Why?
|
Anastomosis, Surgical | 10 | 2021 | 983 | 0.440 |
Why?
|
Retrospective Studies | 51 | 2023 | 76631 | 0.420 |
Why?
|
Angiography | 1 | 2018 | 1634 | 0.420 |
Why?
|
Neoadjuvant Therapy | 7 | 2019 | 2688 | 0.410 |
Why?
|
Myasthenia Gravis | 1 | 2014 | 201 | 0.410 |
Why?
|
Muscle, Skeletal | 4 | 2020 | 4920 | 0.390 |
Why?
|
Bronchial Diseases | 3 | 2005 | 151 | 0.390 |
Why?
|
Pulmonary Artery | 1 | 2019 | 1909 | 0.380 |
Why?
|
Esophagitis | 3 | 2003 | 151 | 0.370 |
Why?
|
Airway Obstruction | 5 | 2010 | 663 | 0.370 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2014 | 599 | 0.370 |
Why?
|
Carcinoma, Squamous Cell | 11 | 2019 | 4014 | 0.360 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 646 | 0.350 |
Why?
|
Humans | 133 | 2023 | 739398 | 0.350 |
Why?
|
Deglutition Disorders | 5 | 2017 | 607 | 0.330 |
Why?
|
Esophageal Diseases | 4 | 2008 | 165 | 0.330 |
Why?
|
Treatment Outcome | 36 | 2022 | 62693 | 0.320 |
Why?
|
Reoperation | 7 | 2021 | 4192 | 0.310 |
Why?
|
Respiratory Tract Fistula | 1 | 2007 | 26 | 0.310 |
Why?
|
Patient Selection | 4 | 2019 | 4211 | 0.300 |
Why?
|
Granular Cell Tumor | 1 | 2007 | 52 | 0.300 |
Why?
|
Male | 90 | 2021 | 349022 | 0.300 |
Why?
|
Esophageal Perforation | 3 | 2022 | 70 | 0.300 |
Why?
|
Cutaneous Fistula | 1 | 2007 | 78 | 0.300 |
Why?
|
Thyroidectomy | 2 | 2010 | 876 | 0.290 |
Why?
|
Survival Rate | 17 | 2021 | 12761 | 0.290 |
Why?
|
Middle Aged | 73 | 2022 | 212863 | 0.290 |
Why?
|
Aged | 66 | 2022 | 162698 | 0.290 |
Why?
|
Quality Improvement | 7 | 2019 | 3730 | 0.290 |
Why?
|
Female | 87 | 2021 | 378853 | 0.280 |
Why?
|
Bronchoscopy | 5 | 2021 | 856 | 0.270 |
Why?
|
Bronchi | 3 | 2019 | 838 | 0.270 |
Why?
|
Sarcopenia | 2 | 2021 | 364 | 0.260 |
Why?
|
Thyroid Neoplasms | 2 | 2010 | 2267 | 0.260 |
Why?
|
Esophageal Achalasia | 1 | 2006 | 91 | 0.260 |
Why?
|
Advisory Committees | 3 | 2018 | 770 | 0.260 |
Why?
|
Gastric Emptying | 2 | 2021 | 232 | 0.260 |
Why?
|
Diverticulum | 1 | 2006 | 136 | 0.250 |
Why?
|
Pleura | 2 | 2020 | 233 | 0.250 |
Why?
|
Survival Analysis | 10 | 2021 | 10247 | 0.240 |
Why?
|
Thoracic Neoplasms | 1 | 2006 | 267 | 0.230 |
Why?
|
Thoracotomy | 5 | 2017 | 365 | 0.230 |
Why?
|
Mesothelioma | 1 | 2009 | 817 | 0.220 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2006 | 485 | 0.210 |
Why?
|
Stents | 4 | 2022 | 3257 | 0.210 |
Why?
|
Bronchial Fistula | 2 | 2018 | 85 | 0.210 |
Why?
|
Pulmonary Emphysema | 3 | 1996 | 670 | 0.210 |
Why?
|
Intussusception | 1 | 2003 | 117 | 0.210 |
Why?
|
Gastroesophageal Reflux | 3 | 2006 | 782 | 0.200 |
Why?
|
Adenocarcinoma | 11 | 2019 | 6318 | 0.200 |
Why?
|
Esophageal Stenosis | 3 | 2009 | 194 | 0.200 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2019 | 9122 | 0.190 |
Why?
|
Barrett Esophagus | 3 | 2011 | 492 | 0.190 |
Why?
|
Jejunum | 2 | 1993 | 480 | 0.190 |
Why?
|
Internship and Residency | 1 | 2021 | 5761 | 0.190 |
Why?
|
Tomography, X-Ray Computed | 11 | 2022 | 20055 | 0.190 |
Why?
|
Pulmonary Surgical Procedures | 1 | 2020 | 28 | 0.190 |
Why?
|
Follow-Up Studies | 14 | 2021 | 38942 | 0.180 |
Why?
|
Calcinosis | 1 | 2009 | 1493 | 0.180 |
Why?
|
Laryngostenosis | 2 | 2010 | 161 | 0.180 |
Why?
|
Solitary Fibrous Tumors | 1 | 2020 | 72 | 0.180 |
Why?
|
Adult | 45 | 2021 | 213394 | 0.170 |
Why?
|
Catheter Ablation | 2 | 2013 | 2737 | 0.170 |
Why?
|
Colon | 3 | 2008 | 1771 | 0.170 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2010 | 1771 | 0.170 |
Why?
|
Respiration Disorders | 1 | 2022 | 369 | 0.170 |
Why?
|
Gastric Outlet Obstruction | 2 | 2011 | 56 | 0.170 |
Why?
|
Pylorus | 2 | 2011 | 85 | 0.170 |
Why?
|
Education, Medical, Graduate | 2 | 2021 | 2275 | 0.160 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2006 | 1377 | 0.160 |
Why?
|
Acute Kidney Injury | 1 | 2011 | 1941 | 0.160 |
Why?
|
Lung Diseases | 2 | 2009 | 1879 | 0.160 |
Why?
|
Preoperative Care | 2 | 2018 | 2238 | 0.160 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 222 | 0.160 |
Why?
|
Stomach | 2 | 2021 | 696 | 0.160 |
Why?
|
Diverticulum, Esophageal | 1 | 2017 | 13 | 0.160 |
Why?
|
RNA, Neoplasm | 1 | 2020 | 761 | 0.160 |
Why?
|
Thoracoscopy | 2 | 2017 | 178 | 0.150 |
Why?
|
United States | 17 | 2022 | 69573 | 0.150 |
Why?
|
Physician's Role | 1 | 2004 | 943 | 0.150 |
Why?
|
Biopsy | 2 | 2020 | 6722 | 0.140 |
Why?
|
Massachusetts | 4 | 2021 | 8669 | 0.140 |
Why?
|
Candidiasis | 1 | 1999 | 365 | 0.140 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2021 | 446 | 0.140 |
Why?
|
Forecasting | 2 | 2017 | 2952 | 0.140 |
Why?
|
Catheterization | 3 | 2011 | 1466 | 0.130 |
Why?
|
Neoplasm Invasiveness | 6 | 2020 | 3603 | 0.130 |
Why?
|
Neuromuscular Blockade | 1 | 2016 | 146 | 0.130 |
Why?
|
Aged, 80 and over | 23 | 2022 | 57650 | 0.130 |
Why?
|
Databases as Topic | 1 | 2017 | 473 | 0.130 |
Why?
|
Thoracic Diseases | 1 | 2016 | 96 | 0.130 |
Why?
|
Combined Modality Therapy | 7 | 2009 | 8605 | 0.130 |
Why?
|
Lung | 6 | 2022 | 9782 | 0.130 |
Why?
|
Consensus | 2 | 2021 | 2913 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2020 | 1603 | 0.120 |
Why?
|
Hospital Mortality | 5 | 2012 | 5305 | 0.120 |
Why?
|
Necrosis | 4 | 2003 | 1643 | 0.120 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2016 | 320 | 0.120 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4832 | 0.120 |
Why?
|
Length of Stay | 4 | 2020 | 6295 | 0.120 |
Why?
|
Ischemia | 1 | 2003 | 1908 | 0.120 |
Why?
|
Burns, Inhalation | 1 | 1993 | 33 | 0.120 |
Why?
|
Body Composition | 2 | 2020 | 2397 | 0.120 |
Why?
|
Muscle Weakness | 1 | 2016 | 412 | 0.120 |
Why?
|
Esophagogastric Junction | 2 | 2016 | 312 | 0.120 |
Why?
|
Forced Expiratory Volume | 5 | 2019 | 1740 | 0.110 |
Why?
|
Dyspnea | 4 | 2012 | 1295 | 0.110 |
Why?
|
Plasma Cell Granuloma, Pulmonary | 1 | 2013 | 13 | 0.110 |
Why?
|
Risk Factors | 13 | 2022 | 71974 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Incidence | 4 | 2020 | 20913 | 0.110 |
Why?
|
Clinical Trials as Topic | 3 | 2011 | 7897 | 0.110 |
Why?
|
Amyloidosis | 1 | 2020 | 789 | 0.110 |
Why?
|
Solitary Fibrous Tumor, Pleural | 1 | 2012 | 25 | 0.110 |
Why?
|
Muscle Strength | 1 | 2016 | 582 | 0.110 |
Why?
|
Esophageal Fistula | 2 | 2003 | 64 | 0.110 |
Why?
|
Muscular Diseases | 1 | 2016 | 555 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 982 | 0.100 |
Why?
|
Carcinoma, Mucoepidermoid | 2 | 2019 | 90 | 0.100 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3517 | 0.100 |
Why?
|
Fundoplication | 2 | 2017 | 139 | 0.100 |
Why?
|
Esophagoscopy | 2 | 2011 | 390 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2013 | 5003 | 0.100 |
Why?
|
Silicones | 1 | 2012 | 248 | 0.100 |
Why?
|
Benchmarking | 1 | 2017 | 1034 | 0.090 |
Why?
|
Computer Simulation | 2 | 2021 | 6237 | 0.090 |
Why?
|
Tracheomalacia | 1 | 2010 | 63 | 0.090 |
Why?
|
Pleurodesis | 1 | 2010 | 41 | 0.090 |
Why?
|
Risk Assessment | 8 | 2018 | 23294 | 0.090 |
Why?
|
Research | 1 | 2018 | 2001 | 0.090 |
Why?
|
Risk Adjustment | 2 | 2017 | 591 | 0.090 |
Why?
|
General Surgery | 1 | 2021 | 1630 | 0.090 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2009 | 88 | 0.090 |
Why?
|
Cough | 3 | 2012 | 552 | 0.090 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2623 | 0.090 |
Why?
|
Echocardiography, Transesophageal | 2 | 2021 | 1128 | 0.080 |
Why?
|
Lung Diseases, Interstitial | 1 | 2017 | 804 | 0.080 |
Why?
|
Mediastinal Diseases | 1 | 2009 | 89 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1197 | 0.080 |
Why?
|
Vena Cava, Superior | 1 | 2009 | 193 | 0.080 |
Why?
|
Esophagoplasty | 1 | 2008 | 43 | 0.080 |
Why?
|
Hemoptysis | 2 | 2010 | 155 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2009 | 139 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1376 | 0.080 |
Why?
|
Adipose Tissue | 1 | 2020 | 3280 | 0.080 |
Why?
|
Microsatellite Instability | 1 | 2011 | 673 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2020 | 8400 | 0.080 |
Why?
|
Lymph Node Excision | 2 | 2015 | 1242 | 0.080 |
Why?
|
Lymphangiosarcoma | 1 | 2006 | 13 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 466 | 0.070 |
Why?
|
Sarcoma | 2 | 2011 | 1888 | 0.070 |
Why?
|
Lung Transplantation | 1 | 1996 | 1154 | 0.070 |
Why?
|
Patient Readmission | 1 | 2021 | 3106 | 0.070 |
Why?
|
Osteolysis, Essential | 1 | 2006 | 30 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2009 | 1850 | 0.070 |
Why?
|
Gastric Fistula | 1 | 2007 | 73 | 0.070 |
Why?
|
Clinical Competence | 2 | 2020 | 4671 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2213 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 5 | 2019 | 6516 | 0.070 |
Why?
|
Life Tables | 1 | 2006 | 370 | 0.070 |
Why?
|
Lymphatic Metastasis | 3 | 2015 | 2897 | 0.070 |
Why?
|
Adolescent | 14 | 2019 | 85405 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2006 | 251 | 0.070 |
Why?
|
Recurrence | 2 | 2009 | 8307 | 0.070 |
Why?
|
Time Factors | 8 | 2019 | 40050 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2020 | 19811 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4424 | 0.070 |
Why?
|
Respiratory Sounds | 2 | 2010 | 692 | 0.070 |
Why?
|
Child | 12 | 2019 | 77033 | 0.060 |
Why?
|
Body Mass Index | 2 | 2019 | 12655 | 0.060 |
Why?
|
Hoarseness | 1 | 2005 | 64 | 0.060 |
Why?
|
Radionuclide Imaging | 1 | 2009 | 2028 | 0.060 |
Why?
|
Laryngoscopy | 1 | 2010 | 703 | 0.060 |
Why?
|
Severity of Illness Index | 3 | 2017 | 15511 | 0.060 |
Why?
|
Thymoma | 1 | 2005 | 186 | 0.060 |
Why?
|
Tracheotomy | 1 | 2004 | 166 | 0.060 |
Why?
|
Surgical Wound Dehiscence | 1 | 2004 | 214 | 0.060 |
Why?
|
Stomach Neoplasms | 2 | 2011 | 1318 | 0.060 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2009 | 561 | 0.060 |
Why?
|
Prognosis | 8 | 2020 | 28901 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2005 | 268 | 0.060 |
Why?
|
Salivary Gland Neoplasms | 1 | 2006 | 293 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2009 | 759 | 0.050 |
Why?
|
Chondrosarcoma | 1 | 2005 | 310 | 0.050 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3051 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 53037 | 0.050 |
Why?
|
Morbidity | 2 | 2019 | 1763 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2006 | 929 | 0.050 |
Why?
|
Chest Pain | 1 | 2009 | 1112 | 0.050 |
Why?
|
Immunohistochemistry | 6 | 2020 | 11347 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1253 | 0.050 |
Why?
|
Child, Preschool | 6 | 2019 | 40802 | 0.050 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2010 | 3453 | 0.050 |
Why?
|
Device Removal | 1 | 2006 | 648 | 0.050 |
Why?
|
beta-Galactosidase | 2 | 1999 | 572 | 0.050 |
Why?
|
Radiography | 3 | 2009 | 6998 | 0.050 |
Why?
|
Anastomotic Leak | 1 | 2022 | 162 | 0.050 |
Why?
|
Neoplasms, Fibrous Tissue | 1 | 2001 | 25 | 0.050 |
Why?
|
Equipment Design | 2 | 2003 | 3583 | 0.050 |
Why?
|
Respiratory Function Tests | 3 | 2010 | 1611 | 0.050 |
Why?
|
Hospitals, General | 2 | 2017 | 744 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2016 | 11410 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12237 | 0.050 |
Why?
|
Papillomaviridae | 2 | 1999 | 1117 | 0.050 |
Why?
|
Cohort Studies | 7 | 2020 | 40389 | 0.050 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6871 | 0.040 |
Why?
|
Larynx | 1 | 2004 | 486 | 0.040 |
Why?
|
Perioperative Period | 1 | 2021 | 255 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2003 | 1096 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12948 | 0.040 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2003 | 311 | 0.040 |
Why?
|
Palliative Care | 2 | 2006 | 3461 | 0.040 |
Why?
|
Odds Ratio | 2 | 2009 | 9846 | 0.040 |
Why?
|
Papain | 1 | 1999 | 64 | 0.040 |
Why?
|
Chymotrypsin | 1 | 1999 | 149 | 0.040 |
Why?
|
Leiomyoma | 1 | 2005 | 727 | 0.040 |
Why?
|
Education, Medical, Continuing | 2 | 2017 | 840 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 546 | 0.040 |
Why?
|
Annual Reports as Topic | 1 | 2018 | 33 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2015 | 4546 | 0.040 |
Why?
|
Mentors | 1 | 2004 | 632 | 0.040 |
Why?
|
Cocarcinogenesis | 3 | 1987 | 54 | 0.040 |
Why?
|
Digestive System Neoplasms | 1 | 1999 | 87 | 0.040 |
Why?
|
Surgical Procedures, Operative | 2 | 2004 | 1867 | 0.040 |
Why?
|
Shoulder Fractures | 1 | 1999 | 88 | 0.040 |
Why?
|
Logistic Models | 2 | 2021 | 13402 | 0.040 |
Why?
|
Neurilemmoma | 1 | 2003 | 546 | 0.040 |
Why?
|
Shoulder Dislocation | 1 | 1999 | 122 | 0.040 |
Why?
|
Liposarcoma | 1 | 2001 | 324 | 0.040 |
Why?
|
Immunocompromised Host | 1 | 2003 | 845 | 0.040 |
Why?
|
Hair Follicle | 1 | 1999 | 208 | 0.040 |
Why?
|
Humerus | 1 | 1999 | 264 | 0.040 |
Why?
|
Patient Care Team | 1 | 2008 | 2527 | 0.040 |
Why?
|
Epidermal Growth Factor | 3 | 1998 | 706 | 0.040 |
Why?
|
Foreign-Body Migration | 1 | 1999 | 222 | 0.040 |
Why?
|
Carcinogens | 3 | 1989 | 464 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12951 | 0.040 |
Why?
|
Radiation-Sensitizing Agents | 1 | 1999 | 358 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2016 | 35326 | 0.040 |
Why?
|
Oncogene Proteins, Viral | 1 | 1998 | 362 | 0.040 |
Why?
|
Radiotherapy | 1 | 2003 | 1526 | 0.030 |
Why?
|
Thorax | 1 | 1999 | 547 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 1996 | 143 | 0.030 |
Why?
|
Anorexia | 1 | 2016 | 158 | 0.030 |
Why?
|
Manometry | 1 | 2017 | 440 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2018 | 559 | 0.030 |
Why?
|
Paclitaxel | 2 | 2001 | 1701 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1999 | 623 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2009 | 3029 | 0.030 |
Why?
|
Cisplatin | 2 | 2016 | 1617 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 690 | 0.030 |
Why?
|
Young Adult | 7 | 2019 | 56255 | 0.030 |
Why?
|
Models, Economic | 1 | 2018 | 723 | 0.030 |
Why?
|
Survivors | 1 | 2004 | 2280 | 0.030 |
Why?
|
Carcinoma | 1 | 2005 | 2361 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4582 | 0.030 |
Why?
|
Nausea | 1 | 2016 | 656 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 925 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2003 | 1869 | 0.030 |
Why?
|
Camptothecin | 1 | 2016 | 570 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12328 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1993 | 821 | 0.030 |
Why?
|
Dimethylhydrazines | 2 | 1989 | 12 | 0.030 |
Why?
|
Dilatation | 1 | 1993 | 286 | 0.030 |
Why?
|
Carbon Dioxide | 1 | 1996 | 1142 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1993 | 441 | 0.020 |
Why?
|
Cardia | 1 | 2011 | 57 | 0.020 |
Why?
|
Equipment Failure | 1 | 1994 | 580 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2022 | 3454 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2012 | 664 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2012 | 976 | 0.020 |
Why?
|
Pain | 1 | 2005 | 4923 | 0.020 |
Why?
|
Methylhydrazines | 1 | 1989 | 6 | 0.020 |
Why?
|
Nitrosamines | 2 | 1987 | 87 | 0.020 |
Why?
|
Colitis | 2 | 1989 | 1146 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 552 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1349 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2019 | 15036 | 0.020 |
Why?
|
Age Factors | 3 | 2013 | 18349 | 0.020 |
Why?
|
Transsexualism | 1 | 2012 | 173 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 3909 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1828 | 0.020 |
Why?
|
Carcinoma, Large Cell | 1 | 2008 | 113 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4935 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11668 | 0.020 |
Why?
|
Esophagitis, Peptic | 1 | 2008 | 77 | 0.020 |
Why?
|
Vital Capacity | 1 | 2010 | 922 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1934 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1330 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3508 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6370 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 603 | 0.020 |
Why?
|
Vascular Patency | 1 | 2009 | 888 | 0.020 |
Why?
|
Spirometry | 1 | 2009 | 863 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3514 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 1999 | 5863 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3916 | 0.020 |
Why?
|
Carcinoma, Small Cell | 1 | 2008 | 418 | 0.020 |
Why?
|
Chylothorax | 1 | 2006 | 84 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2881 | 0.020 |
Why?
|
Colonic Neoplasms | 2 | 1989 | 2530 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5462 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 2011 | 789 | 0.020 |
Why?
|
Polypropylenes | 1 | 2005 | 63 | 0.020 |
Why?
|
HIV Infections | 1 | 2012 | 16764 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1029 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Gastroscopy | 1 | 2006 | 205 | 0.020 |
Why?
|
Granulation Tissue | 1 | 2004 | 93 | 0.020 |
Why?
|
Infant | 2 | 2019 | 34923 | 0.020 |
Why?
|
Sutures | 1 | 1987 | 296 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3526 | 0.020 |
Why?
|
Epidemiologic Methods | 1 | 2010 | 1364 | 0.020 |
Why?
|
Perioperative Care | 1 | 2012 | 995 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2011 | 966 | 0.020 |
Why?
|
Glucocorticoids | 1 | 1993 | 2100 | 0.010 |
Why?
|
Oxygen | 1 | 1996 | 4158 | 0.010 |
Why?
|
Netherlands | 1 | 2008 | 2169 | 0.010 |
Why?
|
Sex Factors | 2 | 2008 | 10398 | 0.010 |
Why?
|
Laminectomy | 1 | 2003 | 232 | 0.010 |
Why?
|
Pancreatic Neoplasms | 3 | 1999 | 5213 | 0.010 |
Why?
|
Genes, Reporter | 2 | 1999 | 1549 | 0.010 |
Why?
|
Renal Insufficiency | 1 | 2008 | 803 | 0.010 |
Why?
|
Smoking | 2 | 2010 | 8960 | 0.010 |
Why?
|
Graft Survival | 1 | 1992 | 3723 | 0.010 |
Why?
|
Vitamin E | 1 | 1986 | 870 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2003 | 1160 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2011 | 6174 | 0.010 |
Why?
|
Drainage | 1 | 2006 | 1139 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 1999 | 9734 | 0.010 |
Why?
|
Transfection | 2 | 1999 | 5884 | 0.010 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1987 | 778 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 2003 | 596 | 0.010 |
Why?
|
Vimentin | 1 | 2001 | 261 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2727 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3036 | 0.010 |
Why?
|
Autopsy | 1 | 2003 | 1004 | 0.010 |
Why?
|
Iontophoresis | 1 | 1999 | 75 | 0.010 |
Why?
|
Regression Analysis | 1 | 2009 | 6452 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1381 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2003 | 915 | 0.010 |
Why?
|
Antigens, CD34 | 1 | 2001 | 656 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9314 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 154 | 0.010 |
Why?
|
1,2-Dimethylhydrazine | 2 | 1989 | 8 | 0.010 |
Why?
|
Transforming Growth Factor alpha | 1 | 1998 | 135 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1999 | 647 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 997 | 0.010 |
Why?
|
Transcription Factor AP-1 | 1 | 1999 | 316 | 0.010 |
Why?
|
Receptor, erbB-3 | 1 | 1998 | 142 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2003 | 1504 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5058 | 0.010 |
Why?
|
Biocompatible Materials | 1 | 2005 | 1730 | 0.010 |
Why?
|
Mesocricetus | 2 | 1987 | 250 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 1998 | 430 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1996 | 116 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3497 | 0.010 |
Why?
|
Liposomes | 1 | 1999 | 760 | 0.010 |
Why?
|
Actins | 1 | 2003 | 2112 | 0.010 |
Why?
|
Transgenes | 1 | 1999 | 1010 | 0.010 |
Why?
|
Mitosis | 1 | 2001 | 1212 | 0.010 |
Why?
|
Neutropenia | 1 | 2001 | 888 | 0.010 |
Why?
|
Gene Expression | 2 | 1999 | 7788 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13237 | 0.010 |
Why?
|
Graft Rejection | 1 | 2008 | 4379 | 0.010 |
Why?
|
Drug Carriers | 1 | 1999 | 693 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1987 | 2196 | 0.010 |
Why?
|
HIV-1 | 1 | 2012 | 6931 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1998 | 2503 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10362 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2008 | 3323 | 0.010 |
Why?
|
Wound Healing | 1 | 2004 | 2768 | 0.010 |
Why?
|
Animals | 9 | 2003 | 168368 | 0.010 |
Why?
|
Models, Statistical | 1 | 2008 | 5113 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1993 | 879 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1993 | 286 | 0.010 |
Why?
|
Cricetinae | 2 | 1987 | 2468 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2003 | 1994 | 0.010 |
Why?
|
Mice | 6 | 1999 | 81002 | 0.010 |
Why?
|
Dexamethasone | 1 | 1999 | 1948 | 0.010 |
Why?
|
Reference Values | 1 | 1999 | 4983 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2001 | 2965 | 0.010 |
Why?
|
Receptors, Glucocorticoid | 1 | 1993 | 302 | 0.010 |
Why?
|
Ligands | 1 | 1998 | 3311 | 0.010 |
Why?
|
Algorithms | 1 | 2010 | 13872 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1998 | 3419 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1998 | 6610 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 1998 | 2370 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1993 | 2732 | 0.000 |
Why?
|
FANFT | 1 | 1987 | 1 | 0.000 |
Why?
|
Mutation | 1 | 2011 | 29658 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1999 | 3671 | 0.000 |
Why?
|
Cystitis | 1 | 1987 | 92 | 0.000 |
Why?
|
Phosphorylation | 1 | 1998 | 8416 | 0.000 |
Why?
|
Rats | 1 | 2003 | 24270 | 0.000 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1986 | 180 | 0.000 |
Why?
|
Free Radicals | 1 | 1986 | 239 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1998 | 10945 | 0.000 |
Why?
|
Acetylcysteine | 1 | 1987 | 273 | 0.000 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4555 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 2003 | 18003 | 0.000 |
Why?
|
Cell Line | 1 | 1998 | 15987 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1986 | 1837 | 0.000 |
Why?
|
Base Sequence | 1 | 1993 | 12804 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1999 | 21863 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1993 | 18125 | 0.000 |
Why?
|
Oncogenes | 1 | 1986 | 1264 | 0.000 |
Why?
|
Skin | 1 | 1993 | 4324 | 0.000 |
Why?
|
Cell Division | 1 | 1986 | 4575 | 0.000 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 2864 | 0.000 |
Why?
|
Body Weight | 1 | 1986 | 4660 | 0.000 |
Why?
|
Quality of Life | 1 | 1996 | 12640 | 0.000 |
Why?
|
Diet | 1 | 1986 | 7876 | 0.000 |
Why?
|